Report overview
Diabetes drugs are treatments for diabetes by lowering the sugar lower in the blood. Diabetes is a kind of disease with common symptoms such as frequent urination, increased thirst and weight loss. The most common drugs used are insulin and oral medications.
This report aims to provide a comprehensive presentation of the global market for Diabetes Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Drugs. This report contains market size and forecasts of Diabetes Drugs in global, including the following market information:
Global Diabetes Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Diabetes Drugs Market Sales, 2018-2023, 2024-2029, (M Units)
Global top five Diabetes Drugs companies in 2022 (%)
The global Diabetes Drugs market was valued at US$ 55070 million in 2022 and is projected to reach US$ 78860 million by 2029, at a CAGR of 5.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Diabetes Drugs key players include Novo Nordisk, Sanofi, Eli Lilly, Merck & Co, Boehringer Ingelheim, etc. Global top five manufacturers hold a share over 80%.
North America is the largest market, with a share over 50%, followed by Europe and China, both have a share over 30%.
In terms of product, Insulin is the largest segment, with a share over 45%. And in terms of application, the largest application is Type 1 Diabetes, followed by Type 2.
We surveyed the Diabetes Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetes Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (M Units)
Global Diabetes Drugs Market Segment Percentages, by Type, 2022 (%)
Insulin
DPP-4
GLP-1
SGLT-2
Global Diabetes Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (M Units)
Global Diabetes Drugs Market Segment Percentages, by Application, 2022 (%)
Type 1 Diabetes
Type 2 Diabetes
Global Diabetes Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (M Units)
Global Diabetes Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diabetes Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Diabetes Drugs revenues share in global market, 2022 (%)
Key companies Diabetes Drugs sales in global market, 2018-2023 (Estimated), (M Units)
Key companies Diabetes Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
AstraZeneca
Bayer
Biocon
Boehringer Ingelheim
Dongbao Pharmaceutical
Eli Lilly
Ganlee
Ginwa
Guangzhou Baiyun Mountain
Hisun Pharmacy
Hua Dong
Huadong Medicine
Jumpcan Pharmacy
KELUN
Merck & Co.
MSD
North China Pharmaceutical Group Corporation
Novartis
Novo Nordisk
Sanofi
SHIJIAZHUANG YILING PHARMACEUTICAL
Takeda
Taloph
Tianan Pharmaceutical
Tonghua DongBao
Wanbang Biopharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Diabetes Drugs, market overview.
Chapter 2: Global Diabetes Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Diabetes Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Diabetes Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Diabetes Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
